EudraGMP Homepage      
 
 
MIA | GMP | API REG | WDA | GDP | Sites Help
Tue 10 Nov 2026 13:03:23 BST
GMP Compliance Menu 
Search
GMP Certificates
Non-Compliance Report
  
The Certificate has been invalidated, invalidated date is : 2025-05-19


Print Preview
                   
Print Preview (Short version)
                  
Back To Search

 

Italian Medicines Agency

CERTIFICATE NUMBER: IT-API/28/H/2025

CERTIFICATE OF GMP COMPLIANCE OF A MANUFACTURER(1) , (2)

Part 1

Issued following an inspection in accordance with
Art. 111(5) of Directive 2001/83/EC as amended

The competent authority of Italy confirms the following:

The manufacturer: Indena S.p.A.

Site address: Via Don Minzoni 6, Settala, 20049

OMS Organisation Id. / OMS Location Id.: ORG-100006081 / LOC-100010689


Is an active substance manufacturer that has been inspected in accordance with Art. 111(1) of Directive 2001/83/EC0.

From the knowledge gained during inspection of this manufacturer, the latest of which was conducted on  2023-10-20 , it is considered that it complies with:

  • The principles of GMP for active substances referred to in Article 47 of Directive 2001/83/EC and an appropriate level of GMP as referred to in Article 46(f) of Directive 2001/83/EC.
    		•

    This certificate reflects the status of the manufacturing site at the time of the inspection noted above and should not be relied upon to reflect the compliance status if more than three years have elapsed since the date of that inspection. However, this period of validity may be reduced or extended using regulatory risk management principles by an entry in the Restrictions or Clarifying remarks field. Updates to restrictions or clarifying remarks can be identified through the EudraGMDP website (https://eudragmdp.ema.europa.eu/). This certificate is valid only when presented with all pages and both Parts 1 and 2.

     The authenticity of this certificate may be verified in EudraGMDP. If it does not appear, please contact the issuing authority.

    __________________________________________________________________________________________________________________________
    (1) The certificate referred to in paragraph Art. 111(5) of Directive 2001/83/ECis also applicable to importers.
    (2) Guidance on the interpretation of this template can be found in the Interpretation of the Union format for GMP certificate.
    (3) These requirements fulfil the GMP recommendations of WHO.

    Part 2

    Human Medicinal Products

    Manufacture of active substance. Names of substances subject to inspection:
    [0000000007118]ROMIDEPSIN(en)
    [0000000004191]TRITERPENIC MIX FROM CENTELLA ASIATICA LEAF (Centella asiatica (L.) Urban)(en)
    [0000000007332]PACLITAXEL FROM WHOLE PLANT(en)
    [0000000007331]PANAX GINSENG ROOT (Panax Ginseng C.A. Meyer) DRY EXTRACT(en)
    [0000000004248]ENOXOLONE(en)
    [0000000004384]RUSCOGENINS(en)
    [0000000001142]COLCHICINE(en)
    [0000000007702]DOCETAXEL TRIHYDRATE(en)
    [0000000007354]SAW PALMETTO FRUIT (Serenoa repens (W. Bartram) Small) soft extract(en)
    [0000000003368]RESERPINE(en)
    [000000000790]MILK THISTLE FRUIT (Silybum Marianum L.GAERTNER) DRY EXTRACT(en)
    [0000000007346]THIOCOLCHICOSIDE (SEMI-SYNTETHIC)(en)
    [0000000006163]CABAZITAXEL(en)
    [000000000100742]CROFELEMER(en)
    [0000000002506]MELPHALAN HYDROCHLORIDE(en)
    [0000000003052]PENTOSAN POLYSULFATE SODIUM(en)
    [0000000001418]DOCETAXEL(en)
    [0000000003795]THIOTEPA(en)
    [0000000008722]CANNABIDIOL (BY EXTRACTION)(en)
    [0000000007349]PRUNUS AFRICANA BARK(Prunus africana (Hook.f.) Kalkman) SOFT EXTRACT CRUDE(en)
    [000000000625]BOLDINE(en)
    [000000000797]CARMUSTINE(en)
    [0000000008788]TIRBANIBULIN(en)
    [0000000001970]GALANTAMINE HYDROBROMIDE(en)
    [0000000004440]BILBERRY FRESH FRUIT (Vaccinium myrtillus L.) DRY EXTRACT STANDARDISED (Ph. Eur.)(en)
    [0000000007212]ST. JOHN''S WORT FLOWERING TOPS (Hypericum perforatum L.) QUANTIFIED DRY EXTRACT(en)
    [0000000007336]BETA-ESCIN (Aesculus hippocastanum L., seed) DRY EXTRACT REFINED(en)
    [0000000007345]PACLITAXEL (SEMI-SYNTHETIC)(en)
    [0000000004971]ACTIVE SUBSTANCES (NON STERILE AND/OR NON BIOLOGICAL, NON FROM HUMAN AND ANIMAL TISSUES, ORGANS, FLUIDS)(en)
    [0000000007347]THIOCOLCHICOSIDE (BY FERMENTATION)(en)

    3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES

    Active Substance:ROMIDEPSIN
    3.3 Manufacturing of Active Substance using Biological Processes
     
    3.3.1  Fermentation
    Special Requirements:
    7.Other:
    Other: Highly toxic products
    3.3.3  Isolation / Purification
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:TRITERPENIC MIX FROM CENTELLA ASIATICA LEAF (Centella asiatica (L.) Urban)
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling, Sieving, Blending
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:PACLITAXEL FROM WHOLE PLANT
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    Special Requirements:
    7.Other:
    Highly toxic products
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:PANAX GINSENG ROOT (Panax Ginseng C.A. Meyer) DRY EXTRACT
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.6  Purification of extracted substance Plant 
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling, Sieving
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:ENOXOLONE
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, Sieving
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:RUSCOGENINS
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, Sieving
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:COLCHICINE
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:DOCETAXEL TRIHYDRATE
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    Special Requirements:
    7.Other:
    Other: Highly toxic products
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, Sieving
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:SAW PALMETTO FRUIT (Serenoa repens (W. Bartram) Small) soft extract
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Other
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:RESERPINE
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:MILK THISTLE FRUIT (Silybum Marianum L.GAERTNER) DRY EXTRACT
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.6  Purification of extracted substance Plant 
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling, Blending
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:THIOCOLCHICOSIDE (SEMI-SYNTETHIC)
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:CABAZITAXEL
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    Special Requirements:
    7.Other:
    Highly toxic products
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    plant source: Taxus baccata, leaves and twigs
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:CROFELEMER
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:MELPHALAN HYDROCHLORIDE
    3.1 Manufacture of Active Substance by Chemical Synthesis
     
    3.1.1  Manufacture of active substance intermediates
    Special Requirements:
    7.Other:
    Highly toxic products
    3.1.3  Salt formation / Purification steps:
    Crystallization
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:PENTOSAN POLYSULFATE SODIUM
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:DOCETAXEL
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    Special Requirements:
    7.Other:
    Highly toxic products
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, Sieving
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:THIOTEPA
    3.1 Manufacture of Active Substance by Chemical Synthesis
     
    3.1.1  Manufacture of active substance intermediates
    Special Requirements:
    7.Other:
    Other: Highly toxic products
    3.1.2  Manufacture of crude active substance
    3.1.3  Salt formation / Purification steps:
    Crystallization
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:CANNABIDIOL (BY EXTRACTION)
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:PRUNUS AFRICANA BARK(Prunus africana (Hook.f.) Kalkman) SOFT EXTRACT CRUDE
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Other
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:BOLDINE
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:CARMUSTINE
    3.1 Manufacture of Active Substance by Chemical Synthesis
     
    3.1.1  Manufacture of active substance intermediates
    Special Requirements:
    7.Other:
    Highly toxic products
    3.1.2  Manufacture of crude active substance
    3.1.3  Salt formation / Purification steps:
    Crystallization
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:TIRBANIBULIN
    3.1 Manufacture of Active Substance by Chemical Synthesis
     
    3.1.1  Manufacture of active substance intermediates
    Special Requirements:
    7.Other:
    Other: Highly toxic products
    3.1.3  Salt formation / Purification steps:
    Crystallization, Salt formation
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:GALANTAMINE HYDROBROMIDE
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, milling, Sieving
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:BILBERRY FRESH FRUIT (Vaccinium myrtillus L.) DRY EXTRACT STANDARDISED (Ph. Eur.)
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.6  Purification of extracted substance Plant 
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, Sieving
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:ST. JOHN''S WORT FLOWERING TOPS (Hypericum perforatum L.) QUANTIFIED DRY EXTRACT
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, Sieving
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:BETA-ESCIN (Aesculus hippocastanum L., seed) DRY EXTRACT REFINED
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.6  Purification of extracted substance Plant 
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying, Spray drying, Sieving
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:PACLITAXEL (SEMI-SYNTHETIC)
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    Special Requirements:
    7.Other:
    Other: Highly toxic products
    3.2.5  Modification of extracted substance Plant 
    3.2.6  Purification of extracted substance Plant 
    3.2.7  Other:
    Other
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    Active Substance:ACTIVE SUBSTANCES (NON STERILE AND/OR NON BIOLOGICAL, NON FROM HUMAN AND ANIMAL TISSUES, ORGANS, FLUIDS)
    3.5 General Finishing Steps
     
    3.5.4  Other:
    Storage

    Active Substance:THIOCOLCHICOSIDE (BY FERMENTATION)
    3.2 Extraction of Active Substance from Natural Sources
     
    3.2.1  Extraction of substance from plant source
    3.2.5  Modification of extracted substance Plant 
    3.2.7  Other:
    plant source: Gloriosa superba L., seed
    3.3 Manufacturing of Active Substance using Biological Processes
     
    3.3.1  Fermentation
    3.3.3  Isolation / Purification
    3.5 General Finishing Steps
     
    3.5.1  Physical processing steps:
    Drying
    3.5.2  Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance)
    3.5.3  Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance)
    3.6 Quality Control Testing
     
    3.6.1  Physical / Chemical testing
    3.6.2  Microbiological testing excluding sterility testing

    4. Other Activities - Active Substances:
    Importation of: CENTELLA ASIATICA LEAF (Centella asiatica (L.), Urban) INTERMEDIATE EXTRACT (confidential), THIOCOLCHICOSIDE (SEMI-SYNTETHIC), CRUDE COLCHICINA (confidential), THIOCOLCHICOSIDE

    Clarifying remarks (for public users):
    Imported active substances (AS) marked as confidential undergo further processing within the importing site. Manufactured AS marked as confidential are for clinical use only. The active substances can be manufactured at different concentrations and using different extraction solvents. On a risk-based approach, the validity of the GMP certificate for this manufacturing site is not ore than 42 months from the latest general GMP inspection conducted on 2023/10/20, except for AIFA's re-evaluation of the risk profile.

     

     


    		 
    		 
     
         
     
     
    		 
     
    The EudraGMDP database is maintained and operated by the EMA. Access to the general public is granted in order to enhance availability of information related to the EMA mandate. The content of the database is provided by the National Competent Authorities (NCA) of the EEA. For this reason, the EMA accepts no responsibility or liability whatsoever (including but not limited to any direct or consequential loss or damage it might occur to you and/or any other third party) arising out of or in connection with the information on this database. Any questions about the content should be addressed to the relevant NCA. Please click here to get list of NCA's.

    For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI.

    Documents issued by UK authorities up to and including 31 December 2020 remain available for consultation in EudraGMDP. However, they are no longer included or updated from 1 January 2021, with the exception of the documents pertaining to sites located in Northern Ireland.
    [EMA © 2014. EudraGMDP 6.5.4.8 build 2026/01/16 09:45]